EuroIntervention

🎙️ Our new podcast Turning Point launches today! In Episode 1, Patrick W. Serruys joins host @aayshacader to reflect on a life of bold choices, innovation & mentorship. 🎧 Listen now: bit.ly/4520lbQ

NEW ISSUE OUT! 📌 State-of-the-art review on the imaging of atherosclerotic plaques; 📌 Low-dose prasugrel monotherapy in ACS; 📌 Supersaturated oxygen therapy in acute anterior MI; 📌 Resting pullback pressure gradient; 📌 Nicardipine and coronary hyperaemia; 📌…

Absolutely honoured to have done this for @EuroInterventio Thank u for this incredible experience @DFCapodanno @EuroInterventio & for all your hard work behind the scenes! @RonnieLass @Syllho & team! 🎙️Episode 1 is out! 🎧here eurointervention.pcronline.com/pages/turning-… @Spotify @ApplePodcasts

📌 HALT after TAVI: variable response to DOACs This case-based report highlights haemodynamic valve deterioration (HVD) linked to HALT, with heterogeneous outcomes to DOAC therapy. Warfarin may be more effective in selected cases. @AliSahebHusain ow.ly/Kltr50WuFhU #TAVI…

This State-of-the-Art review aims to facilitate a comprehensive assessment of plaque pathology using coronary imaging. It outlines how imaging characterizes plaque components and phenotypes, links plaque features to clinical events, and summarizes trials using serial imaging to…

A 1-month prasugrel-based DAPT followed by low-dose monotherapy significantly reduced 12-month adverse events vs 12-month DAPT in ACS patients treated with drug-coated stents. 🔻 49% lower NACE 🔻 77% lower bleeding No increase in ischaemic events. ow.ly/5NsV50WtYHI…

📢 NEW State-of-the-Art Review Advanced coronary imaging techniques—IVUS, OCT, NIRS, and CCTA—enable detailed assessment of plaque morphology, vulnerability, and therapeutic response. This comprehensive review by García-García et al. outlines current evidence and clinical…

Guess what’s still missing from #PCRLV? 👉Your submissions! Send in your Scientific Abstracts, Clinical Cases, Innovations and Late-Breaking Trials by 2 September 📩 🗓️PCR London Valves | 16-18 November pcronline.com/Courses/PCR-Lo…

How to manage a stalled burr: tips and tricks 🔗pcronline.com/Cases-resource… An 80-year-old patient with severe LAD calcification, a tricky rotablation, and one big question: what’s your first move to safely retrieve the burr and finish the job? View part 1⃣ of this #Euro4C…

The DECISION QFR Trial shows #QFR is a viable alternative to FFR for revascularization in multivessel disease, offering substantial agreement in treatment decisions and shorter procedure times. #EIJBestOf ow.ly/tsEy50WkVGv

A serial OCT analysis after PCI with drug-coated balloons for de novo coronary lesions characterises restenosis patterns observed at target lesion revascularisation. The analysis supports further refinement of imaging-based DCB strategies. ow.ly/y2xp50WrExA #DCB #PCI #OCT…

Comparative analysis of latest-generation intra-annular and supra-annular self-expanding valves after TAVI in patients with small aortic annulus found similar early clinical outcomes, with some differences in echocardiographic parameters. #TAVI #Cardiology ow.ly/IC4A50WqcME

🚨 3-yr data: BioMime Morph SES shows 98.8% TLF-free survival, 0.24% ST, 0.5% mortality in very long lesions (50–60 mm). No overlaps. No IVUS. Strong real-world outcomes. 📄asiaintervention.org/article/long-t… @APSIC6 @EuroInterventio @PCRonline

Thanks for sharing @DFCapodanno I personally still don’t know what to propose post TAVI. Apart from those with clear indications for DAPT or NOAC, I tend to stay with aspirin alone 🤷🏾‍♂️ @PCRonline

Four-year follow-up data from this multicentre study of the balloon-expandable Myval TAVI system report valve-related outcomes including haemodynamic deterioration, bioprosthetic valve failure, and patient–prosthesis mismatch, as defined by VARC-3. eurointervention.pcronline.com/article/four-y… #TAVI…

In this randomized trial, OAC did not outperform DAPT in preventing cerebral microembolism post-TAVI. DW-MRI findings suggest DAPT may lead to lower total embolic volume at 90 days. 🔗 ow.ly/J9b050Wn4tf #TAVI #StrokePrevention

The PARTHENOPE trial showed that polymer-free amphilimus-eluting stents (AES) are non-inferior to biodegradable-polymer everolimus-eluting stents (EES) for PCI outcomes at 1 year. AES outcomes were comparable overall, with results adding to evidence on DES options. Full details:…

IVUS is the winner. happy to see that very few are still angio-based. CT will be coming. and surprise about OCT...the ability to measure Ca thickness is not enough? @PCRonline @ColletCarlos @JEscaned @mirvatalasnag

Join the next PCR Webinar in collaboration with India Valves to discuss step-by-step TAVI procedure in Europe and India ⌚️Thursday 24 July, 5:00pm to 6:30pm (UTC+2) 👨‍⚕️A.B. Gopalamurugan, B. Prendergast, @SengottuveluG and @didier_tchetche 🔗 Register now: pcronline.com/Webinars/PCR-W…

Inflammation plays a key role in atherosclerotic cardiovascular disease and residual CV risk. Colchicine was the first anti-inflammatory drug recommended for ACS/CCS—but never with a Class I endorsement. 🧪 A recent RCT showed neutral results, casting doubt on its true benefit…